eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | melanoma, malignant |
| Comorbidity | C0011860|type ii diabetes |
| Sentences | 1 |
| PubMedID- 24600206 | Our results indicate that combinations of inhibitors of the pi3k/akt pathway and dtic or braf inhibitors may be useful to improve the therapeutic efficacy in the treatment of melanoma, in particular, in patients with obesity and type ii diabetes who have elevated serum insulin levels. |
Page: 1